北京大學(xué)腫瘤醫(yī)院胃腸腫瘤中心二病區(qū)副主任醫(yī)師、教學(xué)秘書(shū)、外科教研室秘書(shū)。現(xiàn)任中國(guó)醫(yī)療保健國(guó)際交流促進(jìn)會(huì)結(jié)直腸病學(xué)分會(huì)委員、北京慢性病防治與健康教育研究會(huì)胃腸疾病專委會(huì)委員。師從國(guó)際胃癌協(xié)會(huì)主席、中國(guó)著名腫瘤學(xué)專家季加孚教授。2010-2012年至美國(guó)加州大學(xué)舊金山分校(UCSF)醫(yī)學(xué)中心進(jìn)行胃癌等消化系統(tǒng)腫瘤發(fā)病機(jī)制研究，參加其附屬Benioff醫(yī)院的病案討論及臨床觀摩。2013年獲得北京大學(xué)腫瘤學(xué)博士學(xué)位。工作后，2013.09-2015.08在北京大學(xué)第一醫(yī)院外科培訓(xùn)基地參加北京市?？漆t(yī)師規(guī)范化培訓(xùn)。2015.09-2018.09在北京腫瘤醫(yī)院參加胃腸腫瘤亞?？漆t(yī)師規(guī)范化培訓(xùn)并以優(yōu)異成績(jī)通過(guò)培訓(xùn)測(cè)試。目前主要從事胃腸道腫瘤的外科診治，開(kāi)展胃腸道腫瘤的根治手術(shù)、腹腔鏡微創(chuàng)手術(shù)、注重患者神經(jīng)功能保護(hù)和快速康復(fù)。在臨床實(shí)踐的基礎(chǔ)上，同時(shí)還進(jìn)行胃腸腫瘤的基礎(chǔ)及臨床研究。主持/參與多項(xiàng)國(guó)家級(jí)研究項(xiàng)目，如國(guó)家自然科學(xué)基金重大研究計(jì)劃、國(guó)家自然科學(xué)基金面上項(xiàng)目、國(guó)自然青年科學(xué)基金等。作為第一作者/并列第一作者國(guó)際及國(guó)內(nèi)期刊發(fā)表多篇學(xué)術(shù)成果。曾受邀在美國(guó)UCSF癌癥中心學(xué)術(shù)會(huì)議、第10、11屆國(guó)際胃癌學(xué)術(shù)會(huì)議、第13屆全國(guó)胃癌會(huì)議進(jìn)行會(huì)議發(fā)言。參編《胃癌規(guī)范化手術(shù)》、《結(jié)直腸癌規(guī)范化手術(shù)》等專著。獲北京大學(xué)2011-2012年度創(chuàng)新獎(jiǎng)、第十屆國(guó)際胃癌會(huì)議最佳口頭報(bào)告獎(jiǎng)、第88屆日本胃癌學(xué)術(shù)年會(huì)青年學(xué)者獎(jiǎng)。2021、2022、2023年別獲評(píng)北京大學(xué)腫瘤醫(yī)院優(yōu)秀帶教教師、優(yōu)秀專培教師、教學(xué)管理先進(jìn)個(gè)人。

發(fā)表論文

代表性論文：

1、Kang B#, Camps J#, Fan B#, Jiang H#, Ibrahim MM, Hu X, Qin S, Kirchhoff D, Chiang DY, Wang S, Ye Y, Shen Z*, Bu Z*, Zhang Z*, Roider HG*. Parallel single-cell and bulk transcriptome analyses reveal key features of the gastric tumor microenvironment. Genome Biol. 2022 Dec 22;23(1):265.

2、Huangfu L#, Fan B#, Wang G, Gan X, Tian S, He Q, Yao Q, Shi J, Li X, Du H, Gao X, Xing X, Ji J. Novel prognostic marker LINC00205 promotes tumorigenesis and metastasis by competitively suppressing miRNA-26a in gastric cancer. Cell Death Discov. 2022 Jan 10;8(1):5.

3、Fan B, Ji K, Bu Z, Zhang J, Yang H, Li J, Wu X. ARHGAP11A Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer. Front Mol Biosci. 2021 Oct 18;8:720645.

4、Lu X, Peng B, Chen G, Pes MG, Ribback S, Ament C, Xu H, Pal R, Rodrigues PM, Banales JM, Evert M, Calvisi DF, Chen X, Fan B*, Wang J*. YAP Accelerates Notch-Driven Cholangiocarcinogenesis via mTORC1 in Mice. Am J Pathol. 2021 Sep;191(9):1651-1667.

5、Fan B, Bu Z, Zhang J, Zong X, Ji X, Fu T, Jia Z, Zhang Y, Wu X. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery. BMC Cancer. 2021 Mar 2;21(1):216.

6、Hu X#, Chen L#, Du Y#, Fan B#, et al. Postoperative Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer (RESCUE-GC Study): A Protocol for a Phase III Randomized Controlled Trial. Chin J Cancer Res. 2017 Apr;29(2):144-148.

7、Li L#, Wen XZ#, Bu ZD, Cheng XJ, Xing XF, Wang XH, Zhang LH, Guo T, Du H, Hu Y, Fan B*, Ji JF*.Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells. Oncol Rep. 2016 May;35(5):3009-17.

8、Li Z#, Fan B#, Shan F#, Tang L, Bu Z, Wu A, Zhang L, Wu X, Zong X, Li S, Ren H, Ji J. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study. World J Surg Oncol. 2015 Jul 1;13:212.

9、Fan B#, Zhang LH#, Jia YN, Zhong XY, Liu YQ, Cheng XJ, Wang XH, Xing XF, Hu Y, Li YA, Du H, Zhao W, Niu ZJ, Lu AP, Li JY, Ji JF. Presence of S100A9-positive inflammatory cells in cancer tissues correlates with an early stage cancer and a better prognosis in patients with gastric cancer. BMC Cancer. 2012 Jul 28;12:316.

10、Fan B#, Malato Y#, Calvisi DF#, Naqvi S, Razumilava N, Ribback S, Gores GJ, Dombrowski F, Evert M, Chen X, Willenbring H. Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest. 2012 Aug;122(8):2911-5.